Entropy Technologies LP lowered its position in shares of Teleflex Incorporated (NYSE:TFX – Free Report) by 66.7% during the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 2,793 shares of the medical technology company’s stock after selling 5,591 shares during the quarter. Entropy Technologies LP’s holdings in Teleflex were worth $334,000 as of its most recent filing with the Securities & Exchange Commission.
Several other institutional investors also recently modified their holdings of the business. Banque Cantonale Vaudoise lifted its holdings in Teleflex by 82.5% during the fourth quarter. Banque Cantonale Vaudoise now owns 250 shares of the medical technology company’s stock worth $31,000 after acquiring an additional 113 shares during the period. V Square Quantitative Management LLC bought a new position in Teleflex in the 4th quarter valued at $37,000. UMB Bank n.a. increased its position in shares of Teleflex by 57.1% during the 4th quarter. UMB Bank n.a. now owns 311 shares of the medical technology company’s stock valued at $38,000 after purchasing an additional 113 shares during the last quarter. Sound Income Strategies LLC bought a new stake in shares of Teleflex during the 4th quarter worth $45,000. Finally, Kestra Advisory Services LLC purchased a new position in shares of Teleflex in the 4th quarter worth about $45,000. 95.62% of the stock is owned by institutional investors.
Wall Street Analyst Weigh In
A number of analysts recently issued reports on TFX shares. Truist Financial restated a “hold” rating and set a $143.00 price objective (up from $135.00) on shares of Teleflex in a report on Monday, May 11th. Wall Street Zen upgraded shares of Teleflex from a “sell” rating to a “hold” rating in a research note on Saturday, June 27th. Royal Bank Of Canada raised Teleflex from a “sector perform” rating to an “outperform” rating and increased their price objective for the company from $135.00 to $155.00 in a report on Friday, May 8th. Mizuho raised their target price on Teleflex from $140.00 to $145.00 and gave the stock a “neutral” rating in a research report on Wednesday, July 15th. Finally, BMO Capital Markets began coverage on Teleflex in a report on Wednesday, July 8th. They issued an “outperform” rating and a $159.00 price objective for the company. One analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating, six have given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the stock has an average rating of “Hold” and an average target price of $147.70.
Teleflex Price Performance
Teleflex stock opened at $132.34 on Friday. The firm has a market capitalization of $5.86 billion, a P/E ratio of -5.80, a PEG ratio of 1.00 and a beta of 0.82. Teleflex Incorporated has a one year low of $100.18 and a one year high of $139.67. The company has a debt-to-equity ratio of 0.82, a current ratio of 2.55 and a quick ratio of 2.03. The business has a fifty day moving average price of $130.88 and a 200-day moving average price of $121.26.
Teleflex (NYSE:TFX – Get Free Report) last issued its quarterly earnings data on Thursday, May 7th. The medical technology company reported $1.39 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.21 by $0.18. The business had revenue of $548.30 million for the quarter, compared to analysts’ expectations of $536.91 million. Teleflex had a positive return on equity of 13.29% and a negative net margin of 35.88%.The firm’s quarterly revenue was up 32.3% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.44 EPS. Teleflex has set its FY 2026 guidance at 6.250-6.550 EPS. As a group, equities research analysts forecast that Teleflex Incorporated will post 6.7 EPS for the current year.
Teleflex Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Tuesday, June 30th. Investors of record on Monday, May 25th were issued a dividend of $0.34 per share. This represents a $1.36 dividend on an annualized basis and a yield of 1.0%. The ex-dividend date of this dividend was Friday, May 22nd. Teleflex’s dividend payout ratio is -5.96%.
Teleflex Profile
Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.
The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.
See Also
- Five stocks we like better than Teleflex
- Microsoft Just Flipped the AI Spending Narrative Overnight
- Qualcomm’s Turnaround Is Working, So Why Is Wall Street Selling?
- Meta’s Earnings Show Why Wall Street Is Losing Patience With AI Spending
- Can Starbucks Keep This Turnaround Going? The Latest Results Say Yes
Want to see what other hedge funds are holding TFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teleflex Incorporated (NYSE:TFX – Free Report).
Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.
